School of Medicine
Showing 2,841-2,860 of 12,918 Results
-
Alexander Dunn
Professor of Chemical Engineering
Current Research and Scholarly InterestsMy lab is deeply interested in uncovering the physical principles that underlie the construction of complex, multicellular animal life.
-
James Dunn
Professor of Surgery (Pediatric Surgery)
Current Research and Scholarly InterestsIntestinal lengthening for short bowel syndrome
Intestinal stem cell therapy for intestinal failure
Skin derived precursor cell therapy for enteric neuromuscular dysfunction
Intestinal tissue engineering -
Jeffrey Dunn, MD
Clinical Professor, Adult Neurology
Current Research and Scholarly InterestsTranslational research in the human application of emerging immunotherapies for neurological disease, focusing on Multiple Sclerosis, CIS, transverse myelitis and Neuromyelitis Optica (NMO). Collaborative research with Stanford and extramural scientific faculty to identify biomarkers of disease activity and treatment response in humans. Clinical trials to assess efficacy of emerging treatments for MS, CIS and NMO.
-
Tamara Dunn
Clinical Associate Professor, Medicine - Hematology
BioDr. Tamara Dunn is a clinical associate professor in the Division of Hematology at the Stanford University School of Medicine. She is a clinician with a special interest in medical education, diversity, equity, and inclusion. Specifically, she is committed to improving workforce diversity and creating inclusive workplaces. She is currently the Program Director for the Stanford Hematology/Oncology Fellowship and one of the Associate Chairs of Diversity and Inclusion for the Department of Medicine at Stanford. She is a member of the inaugural American Society of Hematology (ASH) Ambassador Cohort and serves on the ASH Women in Hematology committee, which she co-chairs. She is on the steering committee and is a mentor for Stanford’s Leadership Education in Advancing Diversity (LEAD) program. She takes pride in treating underserved veterans at the Palo Alto Veterans Hospital, where she sees both classical and malignant hematology. Outside of medicine she enjoys singing, dancing, sports (Go Chiefs! Go Warriors!), board games, movies, and spending time with friends and family including her 3 young children, spouse, and energetic vizsla Casey.
-
Mary Laurence Dunne
Affiliate, Medicine - Primary Care and Population Health
BioDr. Mimi Dunne is a physician leader in palliative and emergency medicine with a longstanding commitment to innovation in end-of-life care and medical education. A 2019-2020 Stanford Distinguished Careers Institute Fellow, Dr. Dunne has co-taught MED 296: Being Mortal at Stanford University School of Medicine.
A graduate of Saint Louis University School of Medicine, she completed postgraduate training at the University of Chicago, certification in Mindfulness-Based Stress Reduction at the University of Massachusetts, and is board-certified in both Emergency Medicine and Hospice and Palliative Medicine. As Medical Director of Hudson Valley Hospice, she founded the region’s first palliative care program in 2001.
Her scholarly work spans emergency medicine, palliative medicine, and global health, and she has authored studies, articles, and book chapters in these fields. She currently serves as an advisor to the African Center for Research in End of Life Care in Rwanda and to Bulamu Health Care in Uganda. -
Sebastian Duno-Miranda
Postdoctoral Scholar, Biochemistry
BioPlease see https://duno-miranda.org
-
Nikki Duong, MD
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsMy research interests focus on quality improvement and patient reported outcomes in people with cirrhosis. I also have interests in expanding our breadth of knowledge in caring for patients with gastrointestinal and liver disorders who identify as a sexual and gender minority.
-
Tina Duong MPT, PhD
Senior Research Scientist, Adult Neurology
BioI am a senior research scientist and physical therapist with over 20 years of experience, specializing in neuromuscular clinical research. Currently, I am the Director of clinical outcomes and research developments within the Neuromuscular division and Co-Director, Stanford Innovative Genetic Neurologic Investigation and Treatment Evaluation Center. My doctoral studies focused on understanding the impact of contracture development on subsequent musculoskeletal and biomechanical changes that influence overall functional outcomes. I am deeply committed to advancing my work by creating innovative outcome measures that bridge the gap with traditional metrics for a range of neuromuscular disorders. Furthermore, I am enthusiastic about investigating the therapeutic advantages of incorporating rehabilitation and exercise as complementary treatments for managing neuromuscular conditions.
In my professional pursuits, I prioritize integrity, work ethic, humility, empathy, leadership, initiative, and drive in all my collaborations. Inspired by Ralph Waldo Emerson's poem “"to know even one life has breathed easier because you have lived. This is to have succeeded", I strive to contribute meaningfully in both my personal and professional endeavors. While it can be challenging to articulate one's accomplishments and impact, I aspire to uphold the values and principles that guide me, serving as a compass in navigating both my personal and professional path. I find it difficult to summarize my own accomplishments or impact. So I would like to share a recommendation that was written about me in which I hope to refer back as my north star in both my personal and professional life.
"Dr Tina Duong is a world renown physiotherapist, master trainer, clinical investigator, scientific academician and most importantly an INCREDIBLE person. I had the privilege of working with her side by side during the development of a new therapy for spinal muscular atrophy. Her determination to help the scientific community, patients and carers is truly inspiring. Her knowledge and skills place her at the vanguard of clinical translation of data and meaningful patient outcomes. Her capabilities span everything from publications, meeting moderation, speaker events and clinical training. She has instinctive clinical intuition which allows her to support drug development and translation in both early stage and also during pivotal trial design, data interpretation and patient care and management. Her ethical and moral considerations of medicine and science means she is 100% focused on each individual to support them as best as possible and this is obvious from everyone who has worked or knows her. Her passion, energy and knowledge inspires people, teams and countries! Wherever Tina goes and whatever she embarks on now or in the future, the value she brings is like no one else and her impact is immediate. I personally look forward to the next opportunity to work with Tina as a brilliant scholar. She lives the ambition of: “The world is changed by your example, not by your opinion” -
George Duran
Cancer Biologist and Laboratory Manager, Medicine - Med/Oncology
Current Role at StanfordCancer biologist specializing in the development of novel chemotherapeutic agents and in mechanisms of drug resistance. Current research ranges from molecular studies to further understand the heterogeneity of T-cell lymphomas, to translational studies of molecular determinants of therapeutic response, and clinical trials that use the body’s immune system to fight cancer cells.
Original research contributions have resulted in the authorship of over eighty publications.
